Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma
一项开放标签、单臂 II 期研究，评估帕博利珠单抗单药治疗一线治疗晚期透明细胞肾细胞癌患者的疗效
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.20.02363
McDermott, David F; Lee, Jae-Lyun; Bjarnason, Georg A; Larkin, James M G; Gafanov, Rustem A; Kochenderfer, Mark D; Jensen, Niels Viggo; Donskov, Frede; Malik, Jahangeer; Poprach, Alexandr; Tykodi, Scott S; Alonso-Gordoa, Teresa; Cho, Daniel C; Geertsen, Poul F; Climent Duran, Miguel Angel; DiSimone, Christopher; Silverman, Rachel Kloss; Perini, Rodolfo F; Schloss, Charles; Atkins, Michael B
